Cardiac reprogramming is a research field and methodological approach focused on converting non-cardiac cell types directly into functional cardiomyocytes or cardiomyocyte progenitors. This process, often achieved through the introduction of specific transcription factors or other molecular cues, represents a significant strategy in regenerative medicine for potentially repairing damaged heart tissue by generating new cardiac cells *in situ* or *ex vivo*.